NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea
· Delayed Price · Currency is KRW 1,704.00
+3.00 (0.18%)
At close: Dec 5, 2025
NGeneBio Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -12,956 | -12,628 | -12,769 | -9,785 | -8,431 |
| Depreciation & Amortization | 2,794 | 2,936 | 1,344 | 1,274 | 1,030 |
| Loss (Gain) From Sale of Assets | 1,924 | 14.8 | 20.85 | 0.99 | 11.15 |
| Asset Writedown & Restructuring Costs | 60.38 | 34.04 | 97.62 | 34.1 | 24.56 |
| Loss (Gain) From Sale of Investments | 433.5 | 503.72 | 526.16 | 144.52 | - |
| Loss (Gain) on Equity Investments | - | - | - | - | -199.05 |
| Stock-Based Compensation | 12.26 | 43.22 | 0.2 | 241.31 | 501.98 |
| Provision & Write-off of Bad Debts | 147.12 | 24.1 | 172.03 | - | - |
| Other Operating Activities | -635.87 | -3,100 | 1,600 | 2,445 | 563.07 |
| Change in Accounts Receivable | 257.23 | 115.76 | 166.34 | 456.28 | -1,134 |
| Change in Inventory | 137.76 | -98.3 | -116.18 | -1,893 | 21.03 |
| Change in Accounts Payable | 64.6 | 202.39 | 93.57 | -103.67 | -218.25 |
| Change in Unearned Revenue | - | -0 | -20.17 | 1.83 | -16.22 |
| Change in Other Net Operating Assets | 766.62 | -479.22 | -282.74 | -636.23 | 323.61 |
| Operating Cash Flow | -6,994 | -12,431 | -9,167 | -7,820 | -7,523 |
| Capital Expenditures | -1,867 | -135.37 | -386.37 | -1,029 | -3,023 |
| Sale of Property, Plant & Equipment | 153.61 | 449.48 | - | - | - |
| Cash Acquisitions | -309.77 | -7,520 | - | - | 20.72 |
| Sale (Purchase) of Intangibles | -91.46 | -103.45 | -441.76 | -196.22 | -349.22 |
| Investment in Securities | -2,960 | 1,499 | 4,885 | 1,918 | -13,348 |
| Other Investing Activities | -23.43 | -186.83 | 74.57 | -107.76 | -679.42 |
| Investing Cash Flow | -5,466 | -5,997 | 4,131 | 585.23 | -17,378 |
| Short-Term Debt Issued | - | 5,900 | - | - | 1,100 |
| Long-Term Debt Issued | - | 5,510 | - | 19,866 | 500 |
| Total Debt Issued | 2,274 | 11,410 | - | 19,866 | 1,600 |
| Short-Term Debt Repaid | - | -3,300 | -500 | -3,600 | - |
| Long-Term Debt Repaid | - | -19,172 | -327.9 | -1,116 | -162.54 |
| Total Debt Repaid | -12,465 | -22,472 | -827.9 | -4,716 | -162.54 |
| Net Debt Issued (Repaid) | -10,191 | -11,062 | -827.9 | 15,151 | 1,437 |
| Issuance of Common Stock | 20,059 | 12,593 | 220.35 | 516.93 | 457.15 |
| Other Financing Activities | -30.55 | 2,022 | - | 130 | - |
| Financing Cash Flow | 9,838 | 3,553 | -607.55 | 15,797 | 1,895 |
| Foreign Exchange Rate Adjustments | 61.85 | 30.41 | 20.72 | 38.95 | 0.11 |
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
| Net Cash Flow | -2,560 | -14,844 | -5,623 | 8,601 | -23,006 |
| Free Cash Flow | -8,861 | -12,566 | -9,553 | -8,849 | -10,546 |
| Free Cash Flow Margin | -88.74% | -220.81% | -219.57% | -80.32% | -147.22% |
| Free Cash Flow Per Share | -456.05 | -754.48 | -753.13 | -709.15 | -852.68 |
| Cash Interest Paid | 367.37 | 366.99 | 81.53 | 146.88 | 141.93 |
| Cash Income Tax Paid | - | -102.83 | 36.48 | 96.12 | 20.01 |
| Levered Free Cash Flow | -19,499 | -15,786 | -10,880 | 5,799 | - |
| Unlevered Free Cash Flow | -18,704 | -14,659 | -9,767 | 6,215 | - |
| Change in Working Capital | 1,226 | -259.38 | -159.18 | -2,175 | -1,024 |
Source: S&P Capital IQ. Standard template. Financial Sources.